These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17437510)

  • 1. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
    Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
    Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
    Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Charmandari E; Johnston A; Brook CG; Hindmarsh PC
    J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children.
    Michelet R; Melin J; Parra-Guillen ZP; Neumann U; Whitaker JM; Stachanow V; Huisinga W; Porter J; Blankenstein O; Ross RJ; Kloft C
    Eur J Endocrinol; 2020 Oct; 183(4):357-368. PubMed ID: 32621587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
    Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
    Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
    Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
    Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulated Salivary Cortisol as a Noninvasive Diagnostic Tool for Adrenal Insufficiency.
    Kim YJ; Kim JH; Hong AR; Park KS; Kim SW; Shin CS; Kim SY
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):628-635. PubMed ID: 32981305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
    Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay.
    Deutschbein T; Broecker-Preuss M; Flitsch J; Jaeger A; Althoff R; Walz MK; Mann K; Petersenn S
    Eur J Endocrinol; 2012 Apr; 166(4):613-8. PubMed ID: 22214924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test.
    Marcus-Perlman Y; Tordjman K; Greenman Y; Limor R; Shenkerman G; Osher E; Stern N
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):215-8. PubMed ID: 16430723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
    Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C
    Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
    Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
    Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients.
    Wong V; Yan T; Donald A; McLean M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):131-7. PubMed ID: 15212655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-release hydrocortisone improves body composition and the glucometabolic profile in patients with secondary adrenal insufficiency.
    Jørgensen NT; Boesen VB; Borresen SW; Christoffersen T; Jørgensen NR; Plomgaard P; Christoffersen C; Watt T; Feldt-Rasmussen U; Klose M
    Endocrine; 2024 Jun; 84(3):1182-1192. PubMed ID: 38345683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.